How Are Companies Like Apple Enhancing EHRs?
Richard E. Anderson, MD, FACP, Chairman and CEO of TDC Group, discusses Apple's move into healthcare and how it is having an impact on electronic health records.
Search
Oppose Virginia SB 536: Medical Liability Cap and Patient Access Concerns
This legislation will more than double the medical malpractice cap and would have a truly significant impact on healthcare practitioners' ability to obtain and afford insurance in Virginia. Learn more and how you can take action.
Dec 05, 2025
As Wearables Improve, They Can Boost Patient Engagement and Lower Risks
More and more patients are tracking their biometrics through a wearable device. Practitioners who embrace and direct this interest can reap rewards in patient engagement and safety.
From
The Doctor’s Advocate
Jan 30, 2025
Off-Label Use: Patient Safety Implications
Once authorized, a drug product may be prescribed by a licensed healthcare practitioner for any use deemed appropriate based on the practitioner’s professional opinion. The governing standard is what other similarly trained practitioners would do—not what the manufacturer of the medication or product recommends.
Sep 05, 2025
Preventing Errors in Preoperative Clearance
Take this course to learn potential communication deficits in clinician-patient communication and how to incorporate an effective communication tool to reduce the risk of patient harm.
From
The Doctor’s Advocate
Third Party (Credentialing Facilities) FAQs
Answers to some of the common questions that third parties ask during the credentialing process
Effective Patient-Assisted Telehealth Assessments
Physicians who practice telemedicine must consider the components needed to complete an effective remote assessment and plan ahead based on their specialty area and the patient’s presenting complaint.
Professional Education
Module 6: Controlled Substance Utilization Review and Evaluation System (CURES) (Innovations and Smart Approaches in Safe Prescribing)
This program reviews the CURES electronic database for Schedule II, III, IV, V controlled substance prescriptions dispensed in California, including time requirements involved when dispensing information needs to be reported (a controlled substance is released to the patient or patient's representative). This module will examine how non-DEA licensed physicians and surgeon practitioners can access CURES data. This module consists of four audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.
Mar 04, 2024
Patient Safety Impact Story: Documentation Can Prevent Litigation
Our experts partnered with a general surgery practice to dramatically improve its after-hours call documentation rate.
From
The Doctor’s Advocate
Hurricanes Helene and Milton Assistance
Due to disruption to member medical practices from Hurricanes Helene and Milton and consistent with direction from state insurance regulation offices, The Doctors Company will adjust policy cancellation and premium installment due dates for affected members. Premium due dates have generally been extended in Florida, Georgia, North Carolina, South Carolina, and Tennessee.
